Navigation Links
CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI
Date:6/4/2008

e monitored for

neutropenia. If neutropenia develops (ANC < 1.3 x 10cubed/microL),

dosing with CellCept should be interrupted or the dose reduced,

appropriate diagnostic tests performed, and the patient managed

appropriately (see DOSAGE AND ADMINISTRATION).

-- Gastrointestinal bleeding (requiring hospitalization) has been observed

in approximately 3% of renal, in 1.7% of cardiac, and in 5.4% of

hepatic transplant patients treated with CellCept 3 g daily.

-- Common adverse events that were reported in greater than or equal to

20% of patients in CellCept group in controlled studies in prevention

of renal, cardiac or hepatic allograft rejection are listed in Table 8

of the ADVERSE REACTIONS section of the complete Prescribing

Information.

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by Med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as a Top Company for Older Workers (AARP) and one of the Best Companies to Work For in America (Fortune). For additional information about the U.S. pharmaceuticals business, visit our website http://www.rocheusa.com. Product and treatment information for U.S. healthcare professionals is available at http://www.RocheExchange.com.

<
'/>"/>
SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function
2. Data Show Rufinamide, an Investigational Adjunctive Treatment for Lennox- Gastaut Syndrome, Reduced Drop Attacks by More Than 40%
3. Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol
4. Data Presented at AAN Show That Lacosamide Significantly Reduced Pain and was Generally Well Tolerated in Patients With Diabetic Neuropathic Pain
5. Medivations Dimebon(TM) Significantly Improved Daily Function in Alzheimers Disease Patients, Resulting in Reduced Need for Caregiver Assistance
6. Lotrel, a Single-Pill Combination for Treating High Blood Pressure, Reduced Cardiovascular Events by 20% in High-Risk Patients
7. Reduced Lung Capacity Accelerates With Diabetes
8. Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases
9. Medivations Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimers Disease Patients, Resulting in Reduced Caregiver Distress
10. Breast Cancer Treatment Is Reduced to One Week
11. Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... 15 Today, Hill-Rom Holdings, Inc. (NYSE: ... progress on significant strategic and financial initiatives at ... The Conference is hosted by Peter H. Soderberg, ... presentations on the following topics: ,, Status ... and development and financial updates Smart technologies ...
(Date:12/15/2009)... -- Genomic Health, Inc. (Nasdaq: GHDX ) today ... type DX® breast cancer test, a multi-gene expression ... of chemotherapy benefit and recurrence risk for patients with ... 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held ... ,, "The breadth of data presented at last week,s ...
(Date:12/15/2009)... Mass., Dec. 15 Decision Resources, one ... for pharmaceutical and healthcare issues, finds that an ... factor for three-quarters of surveyed European oncologists in ... of Avastin for the treatment of breast cancer. ... Forum report entitled European Trends in Targeted ...
Breaking Medicine Technology:Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 2Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 3Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 4Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 5Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 6Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 7Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 2Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 3Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 4Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 5Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 6Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 7For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 2For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 3Transition Therapeutics to Present at Canaccord Adams 29th Annual Global Growth Conference 53950 1Transition Therapeutics to Present at Canaccord Adams 29th Annual Global Growth Conference 53950 2EMBO pioneers pension plan for internationally mobile postdoctoral researchers 9517 1EMBO pioneers pension plan for internationally mobile postdoctoral researchers 9517 2EMBO pioneers pension plan for internationally mobile postdoctoral researchers 9517 3Navigating in the ocean of molecules 9514 1Navigating in the ocean of molecules 9514 2Navigating in the ocean of molecules 9514 3
... a Winning Pursuit, WASHINGTON, Dec. 19 ... President, Foundation for Biomedical,Research:, Biomedical research the ... in 1980 earned Mario Capecchi a Nobel Prize ... Harvard-educated genetics professor,persisted toward his goal. Within four ...
... 19 - When cholesterol-clogged,plaque narrows an artery that feeds ... tiny blood vessels in the heart. As these so-called ... reroute some,of the blood flow around the blockage. Scientists ... to develop and prosper, but without,great success. However, you ...
Other Medicine Technology:Nobel Prize-Winning Discovery 2Nobel Prize-Winning Discovery 3Do-It-Yourself Cardiac Bypass Surgery: All You Need is Walking Shoes 2
(Date:12/15/2009)... premier manufacturer of Spa, Massage, and Medical tables announces its ... adjustable breast comfort system to ease pressure felt while laying ... ... New Freedom, Pennsylvania (PRWEB) December 15, 2009 -- OAKWORKS®, Inc., ... today announced the launch of the Utopian Massage Table with ...
(Date:12/15/2009)... , ... (PRWEB) December 10, 2009 -- Millions of men and women suffer ... clusters of red, blue or purple veins that spider-web across the nose, ... US, it’s been estimated that 25-30% of women and 10-20% of men ... Veinwave has been available for over 8 years in Europe ...
(Date:12/15/2009)... 15 "The entire San Diego Hospice and ... of Sol Price on December 14, 2009. Mr. Price ... loyalty and ethics in his business, community and personal ... who truly understood the responsibility of philanthropy and the ... will live on through his countless philanthropic efforts. We ...
(Date:12/15/2009)... in the Dec. 15 issue of the ... significant associations exist between parent-reported insomnia symptoms and ... young school-aged children. , Results of multivariate ... times more likely in children with gastrointestinal regurgitation ... headaches. Nineteen percent of children met the ...
(Date:12/14/2009)... New Research Focuses on Unmarried Young Adults, Attitudes and ... ,, WASHINGTON, Dec. 15 Nearly all unmarried ... should be planned (94% of men and 86% of ... pregnancy in their lives right now (86% of men ... by The National Campaign to Prevent Teen and Unplanned ...
Breaking Medicine News(10 mins):Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 2Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 3Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 4Health News:Vein Center & CosMed, Inc. Selected as Exclusive St. Louis Provider of FDA-Cleared Device 2Health News:San Diego Hospice and The Institute for Palliative Medicine on the Passing of Sol Price 2Health News:Insomnia symptoms linked with medical complaints in young school-aged children 2Health News:Insomnia symptoms linked with medical complaints in young school-aged children 3Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 2Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 3
... Providence Hospital,and St. John Hospital and Medical ... 15 major teaching hospitals by one of the ... The recognition from Thomson (formally Solucient), recognizes ... hospital-wide,performance., Providence and SJH&MC were two of ...
... or not relatives talk about the familys history of ... and testing for those at moderate risk of developing ... today at the American Society for Preventive Oncology meeting ... African Americans participate less often in genetic counseling and ...
... 18 Healthy Coffee USA,Inc., the marketing arm of ... Wendell Tyler of the San Francisco 49ers, Super,Bowl XIX ... Club of Healthy Coffee USA. Mr. Tyler, a UCLA ... in 1977 where he helped lead the LA Rams ...
... of uric acid in the blood may be an early ... urine albumin level, the standard screening test, reports a study ... the American Society of Nephrology. , The results raise the ... decline of renal function in patients with diabetes. "Thus we ...
... Phoenix Health Systems, a premier,provider of integrated professional ... healthcare organizations, announced today that the Texas,Organization of ... awarded Phoenix Health Systems, Inc. endorsed vendor status.,Prior ... diligence to,make certain the vendor is qualified to ...
... Wis., March 18 ,Cardinal Health and GE ... availability of GE Healthcare,s Myoview(TM) (Tetrofosmin) cardiac,imaging ... specialized,nuclear pharmacies., The agreement will give ... leading myocardial perfusion imaging technetium agent used,in ...
Other Medicine News:Health News:St. John Health Hospitals Honored as Nation's Top 15 Major Teaching Hospitals 2Health News:Family communication impacts attitude about genetic counseling/testing for breast cancer 2Health News:Wendell Tyler, of San Francisco 49ers Super Bowl XIX Fame, Joins Healthy Coffee USA's Founders Club 2Health News:Wendell Tyler, of San Francisco 49ers Super Bowl XIX Fame, Joins Healthy Coffee USA's Founders Club 3Health News:Uric acid may provide early clues to diabetic kidney disease 2Health News:Texas Organization of Rural and Community Hospitals (TORCH) Awards Phoenix Health Systems Endorsed Vendor Status 2Health News:Cardinal Health, GE Healthcare Broaden Relationship to Offer Greater Access to Myoview(TM) Imaging Agent 2Health News:Cardinal Health, GE Healthcare Broaden Relationship to Offer Greater Access to Myoview(TM) Imaging Agent 3Health News:Cardinal Health, GE Healthcare Broaden Relationship to Offer Greater Access to Myoview(TM) Imaging Agent 4
... an automated blood gas analysis system that ... the steps in the analytical process, improve ... The 1st automatic system consists of the ... FLEXQ automatic sample handling system. With 1st ...
... three software components that comprise the ... software components comprise the SmartPill GI ... SmartPill Data Receiver software and SmartPill ... integrated and indispensable parts of the ...
... The FLEXLINK software links sampler, ... the bedside, making data readily ... the risk of incorrect patient ... part of 1st automatic, the ...
... One of three software components that ... ,Three software components comprise the ... Capsule software, SmartPill Data Receiver software ... components are integrated and indispensable parts ...
Medicine Products: